Genmab’s cash cow obtains new approval

FDA has added a new indication to the list for Genmab’s successful cancer drug Darzalex. The Danish biotech company can now look forward to a sizeable milestone payment.

Adm. direktør for Genmab
Photo: Stine Bidstrup

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Græske politikere skal undersøges i Novartis-sag

Det græske parlament har besluttet at nedsætte et særligt udvalg, der skal undersøge politikernes rolle i den påståede Novartis-skandale. Novartis’ græske direktør betvivler, at den overhovedet har fundet sted.

Related articles